Abstract. The effects of somatomedin and certain nucleotides on nuclear labelling of cartilage cells with [3H] thymidine were determined by autoradiography. Segments of costal cartilage from hypophysectomized rats were incubated for 24 h in a basal medium with or without additions and then pulsed for 2 h with [3H]thymidine in the basal medium. Both somatomedin (0.1 U/ml) and Bt2cAMP (10\m=-\4m) increased the number of labelled nuclei, and the combined effects were more than additive. A parallelism between the effects of these agents on nuclear labelling and their effects on total thymidine incorporation into DNA was demonstrated.
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The 8-bromated derivative of cAMP (10\m=-\4m) also enhanced chondrocyte nuclear labelling, but neither 8-Br-5'-AMP (10 \ m=-\ 4m) nor 8-Br-cGMP (10\m=-\4m) exhibited actions of the cAMP analogues. It is concluded that in cartilage obtained from hypophysectomized rats and incubated under the specified conditions (1) both somatomedin and cAMP analogues increase the number of cells synthesizing DNA as well as total thymidine incorporation into DNA, (2) the effects of the hormone and cyclic nucleotide in combination are synergistic, and (3) the increased incorporation of labelled thymidine into DNA reflects increased DNA synthesis and not merely an alteration of the specific activity of the intracellular thymidine nucleotide pool.
Somatomedin, which has been postulated to medi¬ ate the action of growth hormone on skeletal tissues, stimulates thymidine incorporation into cartilage DNA (Daughaday & Reeder 1966; Sal¬ mon & DuVail 1970 (Simnett & Fisher 1973) . Changes in intracellular thymidine pools (Newton et al. 1962; Smets 1969; Kaukel et al. 1972; Roller et al. 1974) or thymidine release from cells into incubation media (Hell et al. 1960; Simnett & Fisher 1973) Presented in part at the 68th Annual Meeting of the International Academy of Pathology, San Francisco, Ca¬ lifornia, March 1979. Supported by the Veterans Administration.
List of chemical abbreviations used ATP (adenosine 5'-triphosphate). cAMP (adenosine 3',5'-cyclic monophosphate). 8-Br-cAMP (8-bromoadenosine 3',5'-cycIic monophos¬ phate). 8-Br-5'-AMP (8-bromoadenosine 5'-monophosphate). 8-Br-cGMP (8-bromoguanosine 3',5'-cyclic monophos¬ phate). Bt2cAMP (N6,2'-0-dibutyryladenosine 3',5'-cyclic monophosphate). Bt2cGMP (N2,2'-0-dibutyrylguanosine 3',5'-cyclic monophosphate). cGMP (guanosine 3',5'-cyclic monophosphate). & Salmon 1975) , was a phos¬ phate-buffered saline which contained glucose (2 mg/ ml), amino acids (in concentrations of Eagle's basal medium for HeLa cells plus 0.1 mM serine), ovalbumin (1 mg/ml), penicillin (100 U/ml), and gentamicin (50 (ig/ml). Somatomedin (Salmon 1972 (Salmon , 1975 (Fig. 1A) . However, sections from tissue which had been incubated in media containing somatomedin (Fig. IB) or BtacAMP (Fig. 1C) consistently exhibited labelled nuclei in numbers greater than the controls. The most strik¬ ing increase in nuclear labelling was produced by tissue incubation in a medium with somatomedin and the cAMP analogue together (Fig. ID) 
